ACTIVITY OF THE SHORT-ACTING THROMBOXANE RECEPTOR ANTAGONIST, SQ-30,741, IN THROMBOLYTIC AND VASOSPASTIC MODELS IN MONKEYS

被引：0

作者：

SCHUMACHER, WA ^{[1
]}

HERAN, CL ^{[1
]}

HARTL, KS ^{[1
]}

OGLETREE, ML ^{[1
]}

机构：

[1] SQUIBB INST MED RES, DEPT PHARMACOL, PRINCETON, NJ 08540 USA

来源：

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1990年 / 253卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：841 / 846

页数：6

共 11 条

[1] STUDIES WITH SQ-30,741 - A THROMBOXANE RECEPTOR ANTAGONIST
OGLETREE, ML
LEUKOTRIENES AND PROSTANOIDS IN HEALTH AND DISEASE, 1989, 3 : 89 - 93
[2] PROTAMINE-INDUCED PULMONARY-HYPERTENSION IN HEPARINIZED MONKEYS AND PIGS IS INHIBITED BY THE THROMBOXANE RECEPTOR ANTAGONIST SQ-30,741
SCHUMACHER, WA
HERAN, CL
OGLETREE, ML
EICOSANOIDS, 1990, 3 (02) : 87 - 93
[3] THE COMBINED ANTIISCHEMIC EFFECTS OF THE THROMBOXANE RECEPTOR ANTAGONIST SQ-30,741 AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR
GROVER, GJ
PARHAM, CS
SCHUMACHER, WA
AMERICAN HEART JOURNAL, 1991, 121 (02) : 426 - 433
[4] THROMBOXANE RECEPTOR BLOCKADE WITH SQ-30,741 IMPROVES POSTISCHEMIC MYOCARDIAL-FUNCTION IN ANESTHETIZED DOGS
GROVER, GJ
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1989, 192 (01): : 56 - 60
[5] THE CARDIOPROTECTIVE EFFECTS OF THE THROMBOXANE RECEPTOR ANTAGONIST SQ 30,741 ARE NOT REVERSED BY ASPIRIN
GROVER, GJ
PARHAM, CS
SCHUMACHER, WA
BASIC RESEARCH IN CARDIOLOGY, 1991, 86 (02) : 99 - 106
[6] MYOCARDIAL SALVAGE EFFICACY OF A THROMBOXANE RECEPTOR ANTAGONIST, SQ-30,741, IN RELATION TO INHIBITION EX-VIVO OF PLATELET-FUNCTION IN THE FERRET
GOMOLL, AW
OGLETREE, ML
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1993, 46 (03) : 233 - 242
[7] THE THROMBOXANE RECEPTOR ANTAGONIST SQ-30,741 REDUCES MYOCARDIAL INFARCT SIZE IN MONKEYS WHEN GIVEN DURING REPERFUSION AT A THRESHOLD DOSE FOR IMPROVING REFLOW DURING THROMBOLYSIS
SCHUMACHER, WA
GROVER, GJ
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) : 883 - 889
[8] EFFECT OF THE THROMBOXANE A2 RECEPTOR ANTAGONIST SQ 30,741 ON ULTIMATE MYOCARDIAL INFARCT SIZE, REPERFUSION INJURY AND CORONARY FLOW RESERVE
GROVER, GJ
SCHUMACHER, WA
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1989, 248 (02): : 484 - 491
[9] THE EFFECT OF THE THROMBOXANE A2 PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONIST SQ 30,741 ON MYOCARDIAL INFARCT SIZE AND BLOOD-FLOW DURING MYOCARDIAL ISCHEMIA AND REPERFUSION
GROVER, GJ
SCHUMACHER, WA
SIMON, M
PARHAM, C
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (06) : 701 - 709
[10] ANTIPLATELET ACTIVITY OF THE LONG-ACTING THROMBOXANE RECEPTOR ANTAGONIST BMS-180,291 IN MONKEYS
SCHUMACHER, WA
STEINBACHER, TE
YOUSSEF, S
OGLETREE, ML
PROSTAGLANDINS, 1992, 44 (05): : 389 - 397

← 1 2 →